Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy.

Схожие документы

• Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: a case report.
  по: White, M C, et al.
  Опубликовано: (1981)
• Effect of continuous subcutaneous insulin infusion on retinopathy.
  по: Bastiaensen, L.
  Опубликовано: (1983)
• ABC of diabetes. Continuous subcutaneous insulin infusion.
  по: Pickup, J C
  Опубликовано: (1982)
• Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
  по: Lyu, Fu-ping, et al.
  Опубликовано: (2020)
• Changes in Insulin Requirements From the Onset of Continuous Subcutaneous Insulin Infusion (CSII) Until Optimization of Glycemic Control
  по: Chico, Ana, et al.
  Опубликовано: (2014)